1.
Carpenedo M, Zappaterra A, Ferrari B, Cotilli G. Sequential Use of Efgartigimod and Romiplostim Restored Platelet Response in Two Multirefractory Thrombocytopenic Patients, Previously Treated with Thrombopoietin Receptor Agonists. Mediterr J Hematol Infect Dis [Internet]. 2023 Feb. 28 [cited 2024 Apr. 14];15(1):e2023021. Available from: https://www.mjhid.org/mjhid/article/view/5240